AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33296972 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) with low resistance (20% MIP for first 2 weeks, 30% MIP thereafter)
Number of subjects: 67
Study 33296972 — intervention group
Group type: COMPARATOR
Intervention: Respiratory exercise group (REG) with nasal breathing and maximum exhalation
Number of subjects: 67
Study 36402670 — intervention group
Group type: EXPERIMENTAL
Intervention: Volanesorsen 300 mg weekly subcutaneous injection
Number of subjects: 40
Study 36402670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36402670 — intervention group
Group type: EXPERIMENTAL
Intervention: Volanesorsen
Number of subjects: 40
Study 32525916 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension prevalence
Number of subjects: 546
Study 32525916 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for hypertension
Number of subjects: 546
Study 32149344 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking Abstinence
Number of subjects: 1000
Study 32149344 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MDE history
Number of subjects: 1000
Study 32149344 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline depression severity
Number of subjects: 1000
Study 32149344 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status at FU
Number of subjects: 1000
Study 33052103 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐compound gel once daily for 28 weeks
Number of subjects: 951
Study 33052103 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol scalp solution twice daily for 28 weeks
Number of subjects: 951
Study 616382680 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin 750 mg intravenous every 12 hours (q12h)
Number of subjects: 122
Study 616382680 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin 1,000 mg intravenous every 8 hours (q8h)
Number of subjects: 122
Study 616382680 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepotidacin 1,000 mg intravenous every 12 hours (q12h)
Number of subjects: 122
Study 616382680 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events reported
Number of subjects: 122
Study 36048411 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-visual storytelling
Number of subjects: 45
Study 36048411 — intervention group
Group type: EXPERIMENTAL
Intervention: Tell-show-do (TSD) technique
Number of subjects: 45
Study 36048411 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 33959935 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEPO 500 IU/kg every other day for 2 weeks
Number of subjects: 316
Study 33959935 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent volume of saline)
Number of subjects: 316
Study 33206052 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Adoption Program (SAP)
Number of subjects: 1195
Study 33206052 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 1195
Study 36478762 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of direct oral anticoagulants (DOAC) within 48 hours of minor or moderate stroke, or at day 6-7 following major stroke.
Number of subjects: 2000
Study 36478762 — intervention group
Group type: COMPARATOR
Intervention: Late initiation of direct oral anticoagulants (DOAC) after day 3-4 following minor stroke, after day 6-7 following moderate stroke and after day 12-14 following major stroke.
Number of subjects: 2000
Study 36478762 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of direct oral anticoagulants (DOAC)
Number of subjects: 2000
Study 36478762 — intervention group
Group type: COMPARATOR
Intervention: Late initiation of direct oral anticoagulants (DOAC)
Number of subjects: 2000
Study 33411195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ekso GT
Number of subjects: 15
Study 33411195 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat
Number of subjects: 15
Study 33411195 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 15
Study 33411195 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground walking
Number of subjects: 15
Study 33411195 — intervention group
Group type: COMPARATOR
Intervention: Robotic treadmill walking
Number of subjects: 15
Study 36364868 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC)
Number of subjects: 23
Study 36364868 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 23
Study 36364868 — intervention group
Group type: COMPARATOR
Intervention: Bovine colostrum (BC) and Placebo milk
Number of subjects: 23
Study 34143698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led self-management support program (6-week duration)
Number of subjects: 154
Study 34143698 — intervention group
Group type: COMPARATOR
Intervention: Standard usual care
Number of subjects: 154
Study 32810355 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP group (multi-disciplinary group education, lifestyle modification, HBPM training)
Number of subjects: 291
Study 32810355 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP group
Number of subjects: 291
Study 32810355 — intervention group
Group type: COMPARATOR
Intervention: RAMP individual group (usual care)
Number of subjects: 291
Study 32810355 — intervention group
Group type: COMPARATOR
Intervention: RAMP individual group
Number of subjects: 291
Study 34350549 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (family mental disorder history)
Number of subjects: 1652
Study 34350549 — intervention group
Group type: EXPERIMENTAL
Intervention: Group S (personal problems)
Number of subjects: 1652
Study 34350549 — intervention group
Group type: EXPERIMENTAL
Intervention: Group BS (both personal problems and family history)
Number of subjects: 1652
Study 34023312 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-step diagnostic testing protocol (75 g, 2-hour oral glucose tolerance test)
Number of subjects: 0
Study 34023312 — intervention group
Group type: COMPARATOR
Intervention: 2-step screening protocol (50 g, 1-hour glucose challenge followed by 100 g, 3-hour oral glucose tolerance test)
Number of subjects: 0
Study 34023312 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-step diagnostic testing protocol
Number of subjects: 0
Study 34023312 — intervention group
Group type: COMPARATOR
Intervention: 2-step screening protocol
Number of subjects: 0
Study 32020414 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus two HIIT sessions (MET+EX)
Number of subjects: 16
Study 32020414 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 16
Study 32020414 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo plus two HIIT sessions (EX+CON)
Number of subjects: 16
Study 32020414 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CON)
Number of subjects: 16
Study 36272969 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Testosterone Undecanoate (TU) therapy
Number of subjects: 69
Study 34721385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) tablets
Number of subjects: 332
Study 34721385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) in addition to pharmacotherapy (SLIT+PT)
Number of subjects: 332
Study 34721385 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy (PT) alone
Number of subjects: 332
Study 35213393 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE) standardized to 150 mg of EGCG b.i.d. for 3 years
Number of subjects: 1001
Study 35213393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1001
Study 32014060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone (4 doses of 1 mL of 40 mg/mL over 1 week, every 2 days)
Number of subjects: 96
Study 32014060 — intervention group
Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (1 mg/kg/day, maximal dose 60 mg/day for 5 days)
Number of subjects: 96
Study 32014060 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic methylprednisolone
Number of subjects: 96
Study 33739381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural human immunodeficiency virus prevention intervention
Number of subjects: 234
Study 35673509 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa (N.S) oil supplement, 2000 mg/d for 8 weeks
Number of subjects: 39
Study 32191366 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (10 sessions)
Number of subjects: 44
Study 32191366 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 32191366 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (adequate dose participants)
Number of subjects: 44
Study 32191366 — intervention group
Group type: COMPARATOR
Intervention: Usual care (adequate dose participants)
Number of subjects: 44
Study 34048643 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic removable traction appliance (ORTA)
Number of subjects: 40
Study 34048643 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group (UCG)
Number of subjects: 40
Study 32926410 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 114
Study 32926410 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings (Acticoat™ and Mepitel™)
Number of subjects: 114
Study 32926410 — intervention group
Group type: COMPARATOR
Intervention: Control group (Standard dressings)
Number of subjects: 114
Study 32926410 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) and Control group
Number of subjects: 114
Study 33963947 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder at 25% (T1)
Number of subjects: 24
Study 33963947 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder at 50% (T2)
Number of subjects: 24
Study 33963947 — intervention group
Group type: COMPARATOR
Intervention: Control (0% hydroponic maize fodder)
Number of subjects: 24
Study 33963947 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic maize fodder supplementation
Number of subjects: 24
Study 32410425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) used until 9:00 pm on the day after operation in the trial group
Number of subjects: 94
Study 32410425 — intervention group
Group type: COMPARATOR
Intervention: Control group with IPC used until 8:00 am the next day after operation
Number of subjects: 94
Study 33305900 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine (0.3 mg/kg)
Number of subjects: 157
Study 33305900 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia (normal saline)
Number of subjects: 157
Study 32977684 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention using a raised bed pool for 3 months
Number of subjects: 104
Study 32977684 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 104
Study 35502922 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostemsavir plus optimized background therapy (OBT)
Number of subjects: 371
Study 35502922 — intervention group
Group type: COMPARATOR
Intervention: Optimized background therapy (OBT)
Number of subjects: 371
Study 35502922 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostemsavir plus OBT
Number of subjects: 371
Study 34172046 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe metabolic acidosis
Number of subjects: 5425
Study 34172046 — intervention group
Group type: EXPERIMENTAL
Intervention: Uraemia
Number of subjects: 5425
Study 36457353 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback training
Number of subjects: 30
Study 36457353 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no biofeedback training)
Number of subjects: 30
Study 35694933 — intervention group
Group type: EXPERIMENTAL
Intervention: Mevidalen (30 mg)
Number of subjects: 340
Study 35694933 — intervention group
Group type: EXPERIMENTAL
Intervention: Mevidalen (10 mg)
Number of subjects: 340
Study 35694933 — intervention group
Group type: EXPERIMENTAL
Intervention: Mevidalen (75 mg)
Number of subjects: 340
Study 35694933 — intervention group
Group type: COMPARATOR
Intervention: Actigraphy
Number of subjects: 340
Study 35694933 — intervention group
Group type: COMPARATOR
Intervention: iPad app tests (DSST and SWM)
Number of subjects: 340
Study 33674869 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted azithromycin treatment (thrice over the following year)
Number of subjects: 48
Study 33674869 — intervention group
Group type: COMPARATOR
Intervention: Delayed azithromycin treatment
Number of subjects: 48
Study 33674869 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted azithromycin treatment
Number of subjects: 48
Study 33674869 — intervention group
Group type: COMPARATOR
Intervention: Mass azithromycin treatment
Number of subjects: 48
Study 32613910 — intervention group
Group type: EXPERIMENTAL
Intervention: Indicator species analysis (ISA)
Number of subjects: 0
Study 35452830 — intervention group
Group type: EXPERIMENTAL
Intervention: CRRT with topical citrate + low-dose LMW heparin-calcium anticoagulation
Number of subjects: 120
Study 35452830 — intervention group
Group type: COMPARATOR
Intervention: CRRT with low molecular weight (LMW) heparin-calcium anticoagulation
Number of subjects: 120
Study 33761839 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Feedback Intervention (PFI)
Number of subjects: 95
Study 33761839 — intervention group
Group type: COMPARATOR
Intervention: Control (smoking information control)
Number of subjects: 95
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanitization procedures
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning procedures
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing (before sanitization)
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Locations (head puller, picker, cropper, scalder)
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling time
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between plants
Number of subjects: 135
Study 32867998 — intervention group
Group type: EXPERIMENTAL
Intervention: Location effect
Number of subjects: 135
Study 35775311 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive diode laser application (90s, 810nm, 2.5W, 50Hz, 10ms)
Number of subjects: 25
Study 35775311 — intervention group
Group type: COMPARATOR
Intervention: Non-activated adjunctive diode laser
Number of subjects: 25
Study 35775311 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive diode laser application
Number of subjects: 25
Study 32694373 — intervention group
Group type: EXPERIMENTAL
Intervention: Postgame PCM cooling packs on the shoulder and forearm
Number of subjects: 16
Study 32694373 — intervention group
Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 16
Study 32780139 — intervention group
Group type: EXPERIMENTAL
Intervention: High add power contact lenses (+2.50 D)
Number of subjects: 294
Study 32780139 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium add power contact lenses (+1.50 D)
Number of subjects: 294
Study 32780139 — intervention group
Group type: COMPARATOR
Intervention: Single-vision contact lenses
Number of subjects: 294
Study 34923515 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased CST variability
Number of subjects: 1752
Study 33137378 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO) 15 mg daily for 6 months
Number of subjects: 20
Study 33137378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32736344 — intervention group
Group type: COMPARATOR
Intervention: HIIT + RT
Number of subjects: 76
Study 32736344 — intervention group
Group type: COMPARATOR
Intervention: MICT + RT
Number of subjects: 76
Study 33957651 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg oral, 36 hours before surgery)
Number of subjects: 110
Study 33957651 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol (400 micrograms buccal, 3 hours before surgery)
Number of subjects: 110
Study 32189654 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-to-child and child-to-parent Information, Education and Communication (IEC) strategy
Number of subjects: 2352
Study 32189654 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IEC strategy)
Number of subjects: 2352
Study 35536245 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity coaching and an activity monitor
Number of subjects: 160
Study 35536245 — intervention group
Group type: COMPARATOR
Intervention: Attention control intervention (modified coaching sessions and an activity monitor)
Number of subjects: 160
Study 32525882 — intervention group
Group type: EXPERIMENTAL
Intervention: Care bundle interventions including chest X-ray, CURB-65 severity score, lower respiratory tract samples, and antibiotics within 8 hours from admission.
Number of subjects: 0
Study 36115950 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/d of iron (Stratum 1)
Number of subjects: 503
Study 36115950 — intervention group
Group type: COMPARATOR
Intervention: 40 mg/d of iron (Stratum 1)
Number of subjects: 503
Study 36115950 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/d of iron (Stratum 2)
Number of subjects: 503
Study 36115950 — intervention group
Group type: COMPARATOR
Intervention: 20 mg/d of iron (Stratum 2)
Number of subjects: 503
Study 33175577 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized mixed liquid meal test (SMT)
Number of subjects: 28
Study 33175577 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 28
Study 34710557 — intervention group
Group type: EXPERIMENTAL
Intervention: Difamilast ointment 1%
Number of subjects: 364
Study 34710557 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 364
Study 34103385 — intervention group
Group type: EXPERIMENTAL
Intervention: ERCC+MI-E
Number of subjects: 26
Study 34103385 — intervention group
Group type: COMPARATOR
Intervention: ERCC alone
Number of subjects: 26
Study 32103920 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial training (T group)
Number of subjects: 20
Study 32103920 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 20
Study 35853580 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week community exercise programme (CEP)
Number of subjects: 56
Study 35853580 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care (control)
Number of subjects: 56
Study 32890575 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 IR sublingual tablet
Number of subjects: 1607
Study 32890575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1607
Study 35668500 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin-piperine co-supplementation (500 mg curcumin + 5 mg piperine, 2 capsules daily for 14 days)
Number of subjects: 46
Study 35668500 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules daily for 14 days)
Number of subjects: 46
Study 32641332 — intervention group
Group type: EXPERIMENTAL
Intervention: SP-NoVideo
Number of subjects: 240
Study 32641332 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP-NoVideo
Number of subjects: 240
Study 32641332 — intervention group
Group type: EXPERIMENTAL
Intervention: SP-Video
Number of subjects: 240
Study 32641332 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP-Video
Number of subjects: 240
Study 34996756 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg orally once daily for 30 days
Number of subjects: 605
Study 34996756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study 34996756 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 605
Study 33528113 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg dapoxetine
Number of subjects: 78
Study 33528113 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg dapoxetine
Number of subjects: 78
Study 32678954 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement and a desiccant material (H)
Number of subjects: 64
Study 32678954 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement and glycine powder (G)
Number of subjects: 64
Study 32678954 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement, desiccant material and glycine powder (HG)
Number of subjects: 64
Study 32678954 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical debridement alone (C)
Number of subjects: 64
Study 35268021 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-free beer enriched with isomaltulose and resistant maltodextrin (IMB)
Number of subjects: 30
Study 35268021 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-free beer enriched with resistant maltodextrin (MB)
Number of subjects: 30
Study 35268021 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread (WB) with IMB
Number of subjects: 30
Study 35268021 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread (WB) with resistant maltodextrin (MB)
Number of subjects: 30
Study 35268021 — intervention group
Group type: COMPARATOR
Intervention: Regular alcohol-free beer (RB)
Number of subjects: 30
Study 33533139 — intervention group
Group type: COMPARATOR
Intervention: Cold water group (Cold Pressor Task)
Number of subjects: 75
Study 33533139 — intervention group
Group type: COMPARATOR
Intervention: Exercise group (isometric grip exercise)
Number of subjects: 75
Study 33533139 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (no manipulation)
Number of subjects: 75
Study 32150722 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based program (7 sessions based on mindfulness-acceptance-commitment approach)
Number of subjects: 168
Study 32150722 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 presentations on sport-injury psychology)
Number of subjects: 168
Study 36068501 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-shaped rotatable connector (YRC)
Number of subjects: 60
Study 36068501 — intervention group
Group type: COMPARATOR
Intervention: Y-shaped connector (YC)
Number of subjects: 60
Study 33413354 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise program, 3 sessions per week for 12 weeks
Number of subjects: 234
Study 33413354 — intervention group
Group type: COMPARATOR
Intervention: Walking, 3 sessions per week for 12 weeks
Number of subjects: 234